BALTIMORE—Womble Bond Dickinson attorney Tom Cawley spoke at Bio+Tech18 Conference, a life sciences and technology event presented by the Maryland Tech Council
In addition, attorneys Kelley Doran, Newt Fowler and Brian Meltzer represented the firm at the conference, which drew more than 400 top technology and life science professionals to Baltimore for the Sept. 20 event.
Cawley moderated a panel discussion titled “Life Science Track: Cancer Immunotherapeutics”. Participants in the panel discussion included VLP Thereapeutics Co-Founder, CEO and Chief Science Officer Dr. Wataru Akahata, Immunomic Therapeutics Senior VP of Research and Development Dr. Teri Heiland and Avidea Technologies Co-Founder and Chief Science Officer Dr. Andrew Ishizuka.
Womble Bond Dickinson also sponsored an after-hours cocktail reception at the conference.
Tom Cawley, Ph.D. , concentrates on biotechnology patent prosecution, opinion work, and client counseling. His work includes the design and implementation of global intellectual property strategies, such as life cycle management for pharmaceuticals and agricultural biotechnology.
Kelley Doran has more than 20 years of experience representing companies in government contracts counseling, negotiations and litigation, representing a broad range of domestic and foreign commercial item, defense and homeland security contractors that sell products and services to federal, state and local governments. He works with companies in such industries as life sciences, information technology, cybersecurity, homeland security and defense and
Newt Fowler ’s practice includes all aspects of business planning and advisory services, private equity and venture financings (for both funds and issuers), mergers and acquisitions, joint ventures and complex commercial transactions, and technology and intellectual property issues, including commercialization strategies, licensing, protection, and other technology transactions. He also advises many of the Baltimore region's leading technology companies and investment funds on organization and structure, financing strategies and investments, equity distribution and rights, and other transactional matters.
Brian Meltzer practices in the area of corporate law with a focus on mergers and acquisitions, private equity & venture capital financing, and general corporate governance. He has experience representing private equity groups, venture capital groups, investors and investment firms, and public and private companies.